A large study on the popular asthma medication salmeterol was halted after researchers uncovered evidence that the drug may pose a slightly higher risk for respiratory and asthma-related deaths among black patients.
A dietary supplement derived from tomatoes may help treat moderately elevated blood pressure, the results of a small study suggest. Researchers in Israel found that a daily dose of tomato extract helped lower blood pressure among 31 men and women with mild hypertension.
With the problem of obesity approaching epidemic proportions, an increasing number of patients who have had bariatric surgery are now turning to plastic surgeons for body contouring to remove excess skin remaining after massive weight loss. Serving the informational needs of these surgeons, Quality Medical Publishing (QMP) is pleased to announce the publication of Body Contouring After Massive Weight Loss, edited by Al S. Aly, MD, FACS, a leading expert on the topic.
Healthy gums may be the key to a healthy heart. A new study has revealed that the treatment of gum disease may reduce the risk of cardiovascular disease.
A team of researchers from Chile and Spain has claimed that a combination of gold nanoparticles and radiation may halt or slow Alzheimer’s disease progression without harming healthy brain cells.
According to the Arndt Schultz Law, substances vary in action depending on whether the concentration is high, medium, or low. High concentrations kill; medium concentrations suppress or inhibit; and low, or minute concentrations stimulate.
Having a sibling with a history of cardiovascular disease carries the same or greater risk as having a parent with a history of the disease, according to a new report from the long-standing Framingham Heart Study conducted by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health (NIH). Personal risk of having a cardiovascular event, such as a heart attack, stroke, or peripheral artery disease, may be raised by as much as 45 percent in middle-aged people whose brother or sister has had such an event.
Initial results of the nation’s largest clinical trial for depression have helped clinicians to track ‘real world’ patients who became symptom-free and to identify those who were resistant to the initial treatment. Participants treated in both medical and specialty mental health care settings experienced a remission of symptoms in 12 to 14 weeks during well-monitored treatment with an antidepressant medication. The study, funded by the National Institutes of Health’s (NIH) National Institute of Mental Health (NIMH), used flexible adjustment of dosages based on quick and easy-to-use clinician ratings of symptoms and patient self-ratings of side effects.
The Food and Drug Administration (FDA) has approved the drug Revlimid (lenalidomide) for the treatment of patients with a subtype of Myelodysplastic Syndrome (MDS). The subtype is MDS patients with deletion 5q cytogenetic abnormality.
Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have determined how a promising drug candidate attacks the bacterium that causes tuberculosis (TB). Published online this week in Proceedings of the National Academy of Sciences, the finding may help scientists optimize the drug candidate, PA-824, which targets Mycobacterium tuberculosis (M. tb).